about
Crystal structure of vascular endothelial growth factor-B in complex with a neutralising antibody Fab fragmentStructural characterisation of native and recombinant forms of the neurotrophic cytokine MKSecondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domainExogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer.Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.The core domain of hepatitis C virus glycoprotein E2 generates potent cross-neutralizing antibodies in guinea pigsEphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)Intravenous immunglobulin binds beta amyloid and modifies its aggregation, neurotoxicity and microglial phagocytosis in vitro.One-step zero-background IgG reformatting of phage-displayed antibody fragments enabling rapid and high-throughput lead identification.Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritisCSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsCrystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362.Platelet-derived growth factor stimulates the release of protein kinase A from the cell membrane.DAN is a secreted glycoprotein related to Xenopus cerberus.Midkine (MK), a retinoic acid (RA)-inducible gene product, produced in E. coli acts on neuronal and HL60 leukemia cells.A robust robotic high-throughput antibody purification platform.rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and FcγRs.The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC.Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex.Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancerMapping of the antibody- and receptor-binding domains of granulocyte colony-stimulating factor using an optical biosensor. Comparison with enzyme-linked immunosorbent assay competition studiesSynergies between micropreparative high-performance liquid chromatography and an instrumental optical biosensorStoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptorOptimizing high throughput antibody purification by using continuous chromatography media
P50
Q27652549-63808406-186A-488B-BD47-D902BB628556Q28264781-84A87834-781F-4DC9-8BD5-702AA03B1DE2Q28910199-63E6E0CA-3D9C-4BF4-A5A7-ECB2B60E716AQ30384833-D5E09159-A203-4B74-98EE-CE3FCD7F436DQ30401056-859664C1-1BC8-47D6-8679-E14198487305Q33612608-9D39C5BD-B71B-42F0-A7D8-037717E48793Q34580168-CE027B49-CCB2-412B-8667-1E1A255ECFE5Q34733689-82BBEED8-2F19-4631-9D67-4B3F2C6CA8BCQ35047152-FA110849-14B6-4B7B-9E8B-25ECDFBCE441Q35777741-5782472A-C57F-4D58-BBF1-F1AA21914F57Q36603223-86788537-A9C7-4E0E-8C79-D5A5F87A2035Q37138955-E77836BF-DE31-447A-B156-6DC3243B30B8Q37621434-C4CE0CBA-55F7-4B6D-BB4F-A7DBE8F73A16Q41486804-988E9577-57D8-4E06-9633-FDA4F396C15EQ48005226-5A501683-FC11-4F4D-B432-22D8EEDF2EA9Q48354097-3A90A1AD-2F31-4219-814B-DE490FE48B86Q50630171-84F71D68-8D0A-4A0D-B2F4-C8A29437CDD0Q52358342-078126CE-FA2B-470B-9F3E-E31E7DBEEA3BQ52914159-DBB66C15-F318-48A0-845C-2E49E5400BBAQ53581146-D4857E82-1C15-4725-92AF-4348993DB75FQ54582911-B8BE9F26-780D-4353-862A-F15FAD38FCB7Q58024112-28D32B09-D28F-45FB-AD43-074A38B72508Q72098093-1052FE2F-AE03-4334-B4D3-67EFDB0509E0Q72342872-805F2D68-F8DD-4039-A46C-5AB78E2853CAQ73833562-67007986-5255-4211-AB08-F48309D23C58Q92656795-70FBD10B-CDB5-49EB-AB07-33F8EC5E18CC
P50
description
researcher
@en
wetenschapper
@nl
name
L Fabri
@en
L Fabri
@nl
type
label
L Fabri
@en
L Fabri
@nl
prefLabel
L Fabri
@en
L Fabri
@nl
P108
P106
P108
P31
P496
0000-0003-4033-3304